Mark Fox
Episode Description:
Pedram sits down with returning guest Mark Fox, a former chief engineer for NASA contractor Morton Thiokol turned PEMF inventor, to discuss the Blue Vibe: a new device combining 40 Hz light and magnetic frequency to address mild cognitive impairment. Mark explains how an accidental MIT discovery about gamma frequency and amyloid plaque led to this dual-action technology, and shares results from a 41-person clinical trial where every single participant improved.
Pedram connects the technology to his own family history with Alzheimer’s and his clinical work linking gut and oral microbiome imbalances to cognitive decline. The conversation covers dosing, long-term use, affordability, and why 40 Hz may be the single most useful frequency for human health.
Listen to the episode on Spotify here or on your favorite podcast platform and check out the Urban Monk Academy here.
Podcast show notes:
[00:00] Introduction and Background on Mark Fox
- Pedram introduces Mark Fox, former chief engineer on the solid rocket boosters for NASA contractor Morton Thiokol, and creator of the original Vibe PEMF device
- Mark explains what drew him to cognitive impairment: three close friends who quit careers to care for parents with dementia
[03:00] The MIT Discovery and the Blue Vibe Device
- MIT researchers accidentally found that 40 Hz flickering light reduced amyloid plaque in mice
- The Blue Vibe uses both 40 Hz light and 40 Hz PEMF simultaneously, worn on the back of the neck or wrist
- Blue light at a specific wavelength targets the brain via acupressure meridian points more effectively than red light
[06:00] The Clinical Trial Results
- 41 participants wore the device one hour a day for 30 days using the validated PROMIS cognitive questionnaire
- 100% of participants showed improvement; P-factor reached 0.000001 (one in four million)
- Two participants said they didn’t feel better, yet their own self-reported scores showed measurable improvement, ruling out placebo effect
[09:00] Study Design and Measurement
- PROMIS is the most widely accepted cognitive behavior survey in clinical settings
- Pre/post scoring across 23–28 questions on frequency of memory lapses, with a 1–10 scale per question
- Mark is now developing a broader comfort and calmness index (H2CI) for future cross-condition studies
[12:00] Long-Term Use and Maintenance
- No controlled data yet on whether benefits persist after stopping use
- Most Vibe users naturally shift to maintenance sessions a few times per week once improvement is achieved
- One case: a 17-year-old’s Tourette’s resolved after two weeks on brain balancing and never returned
[15:00] Clinical Crossover: Gut Microbiome and Cognitive Decline
- Pedram discusses the correlation between oral/gut pathogens (e.g., P. gingivalis) and Alzheimer’s
- The Blue Vibe is being used as adjunctive therapy in Pedram’s gut program for patients with mild cognitive impairment
- No known side effects; one outlier case involved cannabis use competing with the gamma frequency stimulation
[17:00] The 40 Hz Gamma Frequency
- Gamma bursts at 40 Hz are associated with peak cognitive states, religious and aha experiences in meditators
- 40 Hz is broadly documented to reduce inflammation, which underlies an estimated 80% of all human ailments
- Mark considers 40 Hz the single most useful frequency for human health
[20:00] Real-World Results and Testimonials
- An 83-year-old woman began ordering groceries on her phone and dancing in her living room after 10 days of use
- Her daughter (a nurse) reported she didn’t realize her mother had been depressed until it lifted
- Pedram is introducing the device to patients in his gut program and to his own father
[23:00] Pricing and Availability
- Retail price: $499; currently on sale at $349
- Advertising costs five times more than the product itself
- Inventory runs out quickly; Pedram’s audience gets priority access through a dedicated link
Key Takeaways
- 100% of 41 clinical trial participants showed measurable improvement in cognitive function after 30 days of daily use
- The Blue Vibe combines 40 Hz light and PEMF in a single wearable, the only device of its kind using both simultaneously
- 40 Hz gamma frequency is associated with both peak brain states and the reduction of amyloid plaque
- The PROMIS questionnaire results ruled out placebo effect when two participants who doubted the device still showed improvement in their own scores
- Oral and gut microbiome imbalances are directly linked to cognitive decline, making adjunctive therapies like this especially relevant
- At $349, the Blue Vibe is a fraction of the cost of clinical PEMF machines that can run $15,000–$30,000
Resources Mentioned
- Blue Vibe by Vibe (Mark Fox)
- MIT 40 Hz light and amyloid plaque research
- PROMIS cognitive behavior assessment
- Original Vibe PEMF device
- Urban Monk Academy gut microbiome program
This episode is for educational purposes only and not intended as medical advice. Consult with qualified healthcare practitioners for personalized guidance.
www.theurbanmonk.com